Dry Eyes
Ophthalmology
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Seed TherapeuticsContact Lens with alginic acid
Bausch + LombLotemax
Clinical Trials (2)
Total enrollment: 75 patients across 2 trials
Effect of Contact Lens With Alginic Acid in Dry Eye Patients
Start: Feb 2014Est. completion: Dec 2014
N/ACompleted
Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol Etabonate 0.5%
Start: Aug 2011Est. completion: Feb 201575 patients
N/ACompleted
Related Jobs in Ophthalmology
Lead Data Manager
Genomics
Remote
8h ago
Cleanroom and Laboratory Technician
SAB BIO
8h ago
APAC Regulatory Affairs Manager
Johnson & Johnson
Singapore, Singapore
Yesterday
Clinical Operations Manager
Johnson & Johnson
Irvine, California, United States of America
Yesterday
$117K - $201K/yr
Site Delivery Leader MLL
Johnson & Johnson
Gent, East Flanders, Belgium
Yesterday
BM 喀什 PSR HY
Johnson & Johnson
Urumqi, Xinjiang, China
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space